PYTEST® 14C-Urea Breath Test + VOQUEZNA® Triple Pak®

ApprovedActive
0 views this week 0 watching Active
Interest: 41/100
41
Hype Score

Development Stage

Pre-clinical
Phase 1
Phase 2
Phase 3
5
Approved
Indication / Disease

H Pylori Infection

Conditions

H Pylori Infection, H Pylori Gastritis, Gastric Cancer

Trial Timeline

Oct 15, 2022 → Nov 6, 2027

About PYTEST® 14C-Urea Breath Test + VOQUEZNA® Triple Pak®

PYTEST® 14C-Urea Breath Test + VOQUEZNA® Triple Pak® is a approved stage product being developed by Phathom Pharmaceuticals for H Pylori Infection. The current trial status is active. This product is registered under clinical trial identifier NCT07224035. Target conditions include H Pylori Infection, H Pylori Gastritis, Gastric Cancer.

Hype Score Breakdown

Clinical
20
Activity
12
Company
9
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT07224035ApprovedActive